-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QhapUKeE3XMYrUCwlhXMKJSG96uwSfWghAublMnHDd+nOpuA+6n3ftAaf5J4lMnM m3lGsdZWOSNyLGJfgDjTLg== 0000950134-08-012945.txt : 20080718 0000950134-08-012945.hdr.sgml : 20080718 20080718171207 ACCESSION NUMBER: 0000950134-08-012945 CONFORMED SUBMISSION TYPE: POS AM PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080718 DATE AS OF CHANGE: 20080718 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STEMCELLS INC CENTRAL INDEX KEY: 0000883975 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943078125 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: POS AM SEC ACT: 1933 Act SEC FILE NUMBER: 333-128797 FILM NUMBER: 08959913 BUSINESS ADDRESS: STREET 1: 3155 PORTER DRIVE STREET 2: . CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 6504753100 MAIL ADDRESS: STREET 1: 3155 PORTER DRIVE STREET 2: . CITY: PALO ALTO STATE: CA ZIP: 94304 FORMER COMPANY: FORMER CONFORMED NAME: CYTOTHERAPEUTICS INC/DE DATE OF NAME CHANGE: 19930328 POS AM 1 f42241posam.htm POST-EFFECTIVE AMENDMENT NO.1 posam
Registration No. 333-128797
As filed with the Securities and Exchange Commission on July 18, 2008
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO
Form S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
 
StemCells, Inc.
(Exact Name of Registrant as Specified in Its Charter)
     
Delaware
(State or Other Jurisdiction of Incorporation) 		  94-3078125
(I.R.S. Employer Identification No.)
3155 Porter Drive
Palo Alto, CA 94304
(650) 475-3100
(Address, including zip code, and telephone number, including area code of principal executive offices)
Kenneth B. Stratton, Esq.
General Counsel
StemCells, Inc.
3155 Porter Drive
Palo Alto, CA 94304
(650) 475-3100
(Name, address, including zip code, and telephone
number, including area code, of agent for service)
 
Please send copies of all communications to:
Geoffrey Davis, Esq.
Ropes & Gray LLP
One International Place
Boston, Massachusetts 02110
(617) 951-7000
 
Approximate date of commencement of proposed sale to the public Not Applicable
If the only securities being registered on this form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. o
If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”) other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. o
If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o
If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o
If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. o
If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
     
Large accelerated filer o
  Accelerated filer þ
 
    
Non-accelerated filer o (Do not check if a smaller reporting company)
  Smaller reporting company o
 
 

 

 

DEREGISTRATION OF UNSOLD SECURITIES
     This Post-Effective Amendment No. 1 ( “Post-Effective Amendment No. 1”) relates to the Registration Statement on Form S-3 of the Registrant (File No. 333-128797) (the “Registration Statement”) pertaining to the shelf registration of an indeterminate number of shares of the Registrant’s common stock, $0.01 par value per share (“Common Stock”), up to a total dollar amount of $100,000,000, which was filed with the Securities and Exchange Commission on October 3, 2005, as amended by pre-effective Amendment No. 1 on November 3, 2005.
     In accordance with the Registrant’s undertaking in Part II, Item 17(c)(3) of the Registration Statement, this Post-Effective Amendment No. 1 hereby amends the Registration Statement to deregister any shares of Common Stock registered pursuant to the Registration Statement and not otherwise sold thereunder.

 

 

SIGNATURES
     Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Post-Effective Amendment No. 1 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Palo Alto, State of California, on July 18, 2008.
         
  StemCells, Inc.
 		  
  By:   /s/ Martin M. McGlynn    
    Name:   Martin M. McGlynn   
    Title:   President and Chief Executive Officer   
 
     Pursuant to the requirements of the Securities Act of 1933, this Post-Effective Amendment No. 1 has been signed below by the following persons in the capacities indicated and on the dates indicated.
         
/s/ Martin M. McGlynn
 
Martin M. McGlynn
   President and Chief Executive Officer and Director
(principal executive officer) 		  July 18, 2008
 
        
/s/ Rodney K.B. Young
  Chief Financial Officer   July 18, 2008
 
        
Rodney K.B. Young
  (principal financial officer)    
 
        
/s/ George Koshy
  Chief Accounting Officer   July 18, 2008
 
        
George Koshy
  (principal accounting officer)    
 
        
*
  Director   July 18, 2008
 
        
Eric H. Bjerkholt
        
 
        
*
  Director   July 18, 2008
 
        
Ricardo B. Levy, Ph.D.
        
 
        
/s/ Desmond H. O’Connell, Jr.
  Director   July 18, 2008
 
        
Desmond H. O’Connell, Jr.
        
 
        
*
  Director   July 18, 2008
 
        
Roger M. Perlmutter, M.D., Ph.D.
        
 
        
*
  Director, Chairman of the Board   July 18, 2008
 
        
John J. Schwartz, Ph.D.
        
 
        
*
  Director   July 18, 2008
 
        
Irving L. Weissman, M.D.
        
         
     
*By:   /s/ Martin M. McGlynn    
  Martin M. McGlynn
Attorney-in-fact 		  
 

 

-----END PRIVACY-ENHANCED MESSAGE-----